The Limited Times

Now you can see non-English news...

Cancer: the State finances a French-style "Cambridge"


DECRYPTION - The Paris Saclay Cancer Cluster will benefit from 80 to 100 million euros from the government and 150 million from Sanofi.

Five new drugs or medical devices against cancer invented in France by 2027: this is the bet of the Paris Saclay Cancer Cluster (PSCC), launched a year ago by Gustave Roussy, Sanofi, Inserm, the Polytechnic Institute and Paris-Saclay University.

This project - which is anchored in Villejuif where Gustave Roussy is based - will receive funding of 80 to 100 million euros from the State: the government made it official on Monday morning after a meeting on the strategy decade of the fight against cancer.

The PSCC is thus the first winner of a call for expressions of interest launched by Emmanuel Macron as part of the “France 2030” plan.

To discover

  • Prime Macron 2022: conditions, amount, date of payment... how does it work?

The ambition was to identify “global poles of excellence bringing together companies, care, research and breakthrough innovation, [with] the ambition of transforming the landscape of French biomedical research”.

With 1.3 million deaths each year in Europe (+25% expected by 2035), cancer is one of the…

This article is for subscribers only.

You have 80% left to discover.

Cultivating your freedom is cultivating your curiosity.

Keep reading your article for €0.99 for the first month


Already subscribed?


Source: lefigaro

All business articles on 2022-12-05

You may like

Life/Entertain 2023-01-26T09:15:08.480Z
News/Politics 2023-01-24T14:32:32.221Z

Trends 24h

Business 2023-02-02T11:00:23.356Z


© Communities 2019 - Privacy